Journal of Obstetrics and Gynaecology · 2017 · 42 citations · 11 references
MedicineEndocrinologyGynecologyObesity PreventionReproductive EndocrinologyWomen's Health PharmacotherapyDiabetes MellitusInsulin ResistancePolycystic Ovary SyndromeCarnitine SupplementationObesity-associated Insulin ResistancePolycystic Ovary Syndrome ManagementPolycystic Ovary Syndrome TreatmentPolycystic Ovary Syndrome-associated Insulin Resistance
It is well-known that plasma L-carnitine concentrations are significantly decreased in obese individuals. A study showed that L-carnitine concentrations are significantly lower in lean PCOS patients than in lean healthy women. Thus, it has been suggested that lowered L-carnitine is associated with PCOS. This study also showed that the women with PCOS had significantly lower L-carnitine levels than those of the healthy controls. In addition, this study hypothesised that low L-carnitine levels in PCOS patients were associated with obesity and/or insulin resistance. Moreover, plasma L-carnitine concentrations were found to be statistically similar in PCOS patients and healthy controls, when controlled for obesity. This study implied that L-carnitine could be used as an adjunctive therapy in the management of insulin resistance or obesity in women who have PCOS. Further research might be planned to clarify the clinical effects of L-carnitine administration in PCOS patients with insulin resistance and/or obesity.
11
THE JOURNAL OF REPRODUCTIVE MEDICINE
Diane M. Reddy, Sheldon A. Wasserman · AJN American Journal of Nursing · 1999 · 2.5K citations
Medicine, Gynecology, Obstetrics +12